ProShare Advisors’s Catalyst Pharmaceutical CPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $560K | Sell |
|
|||||
|
2025
Q1 | $645K | Sell |
|
|||||
|
2024
Q4 | $703K | Buy |
|
|||||
|
2024
Q3 | $464K | Buy |
|
|||||
|
2024
Q2 | $266K | Sell |
|
|||||
|
2024
Q1 | $358K | Buy |
|
|||||
|
2023
Q4 | $317K | Buy |
|
|||||
|
2023
Q3 | $179K | Buy |
|
|||||
|
2023
Q2 | $203K | Buy |
|
|||||
|
2023
Q1 | $233K | Sell |
|
|||||
|
2022
Q4 | $284K | Buy |
|
|||||
|
2022
Q3 | $169K | Buy |
|
|||||
|
2022
Q2 | $75K | Sell |
|
|||||
|
2022
Q1 | $151K | Sell |
|
|||||
|
2021
Q4 | $143K | Buy |
|
|||||
|
2021
Q3 | $66K | Sell |
|
|||||
|
2021
Q2 | $145K | Sell |
|
|||||
|
2021
Q1 | $120K | Buy |
|
|||||
|
2020
Q4 | $72K | Buy |
|
|||||
|
2020
Q3 | $35K | Sell |
|
|||||
|
2020
Q2 | $61K | Buy |
|
|||||
|
2020
Q1 | – | Sell |
|
|||||
|
2019
Q4 | $49K | Buy |
|
|||||
|
2019
Q3 | $58K | Buy |
|
|||||
|
2019
Q2 | $39K | Sell |
|
|||||
|
2019
Q1 | $53K | Buy |
|
|||||
|
2018
Q4 | $20K | Sell |
|
|||||
|
2018
Q3 | $45K | Sell |
|
|||||
|
2018
Q2 | $40K | Buy |
|
|||||
|
2018
Q1 | $27K | Buy |
|
|||||
|
2017
Q4 | $42K | Buy |
|
|||||
|
2016
Q1 | – | Sell |
|
|||||
|
2015
Q4 | $27K | Buy |
|